5 May 2020 - The Australia, Canada, Singapore, Switzerland Consortium (ACSS) regulatory authorities have pledged their collective support in countering the COVID-19 global pandemic.

To address this worldwide public health crisis, ACSS members are collaborating to advance the regulatory science needed to support the rapid development of diagnostic tests, as well as vaccines and treatments against COVID-19. 

Members are committed to sharing vital information as we investigate and evaluate medical products for quality, safety and efficacy, and strive to ensure that the benefits of any new medical product outweigh its risks.

Read TGA press release